The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26364942 |
9 |
Progress in the development of fatty acid synthase inhibitors as anticancer targets. |
University of South Alabama |
| 26288680 |
10 |
Fatty Acid Synthase (FASN) Inhibitors as Potential Treatment for Cancer, Obesity, and Liver Related Disorders. |
Therachem Research Medilab (India) |
| 25513712 |
11 |
Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase. |
Indiana University School of Medicine |
| 24900571 |
44 |
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. |
3-V Biosciences |
| 21726077 |
51 |
The lipogenesis pathway as a cancer target. |
Wayne State University |
| 24900519 |
3 |
Fatty Acid synthase inhibitors as possible treatment for cancer: patent highlight. |
TBA |
| 16870425 |
14 |
Fatty acid synthase inhibitory activity of acylphloroglucinols isolated from Dryopteris crassirhizoma. |
Korea Research Institute of Bioscience and Biotechnology |
| 16392800 |
209 |
Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli. |
National Institute of Allergy and Infectious Diseases |
| 15026045 |
12 |
Synthesis and evaluation of analogues of S-adenosyl-L-methionine, as inhibitors of the E. coli cyclopropane fatty acid synthase. |
Universit£ |
| 21873051 |
31 |
Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure. |
Boehringer Ingelheim Pharma |
| 20817450 |
13 |
Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana. |
Chinese Academy of Sciences |
| 16784844 |
44 |
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors. |
Merck Research Laboratories |
| 30803804 |
45 |
Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN). |
Forma Therapeutics |
| 12932120 |
3 |
CT2108A and B: New fatty acid synthase inhibitors as antifungal agents. |
Panlabs |
| 12542342 |
2 |
Flavanone glycosides from Miconia trailii. |
University of Mississippi |
| 15715465 |
40 |
Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase. |
Johns Hopkins University |
| 29779975 |
53 |
Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy. |
Janssen Research and Development |
| 28236510 |
55 |
A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids. |
Baylor University |
| 22214209 |
33 |
Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three ß-class carbonic anhydrases from Mycobacterium tuberculosis. |
Universit?? Degli Studi Di Firenze |
| 20222760 |
61 |
Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer. |
Universit?? Lille Nord De France |
| 9879510 |
11 |
Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase. |
Orstom |
| 16640336 |
16 |
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication. |
Schering-Plough Research Institute |
| 19631219 |
29 |
Structural-thermodynamic relationships of interactions in the N-terminal ATP-binding domain of Hsp90. |
University College London |
Search and Browse
